Well, there is the 2015 conference call to discuss finances and an update to corporate strategy coming up in march. Details haven't been released yet, but that's all the information I could get from the Leah at Investor Relations.
Maybe they sold some assets related to their previous drug failure and are planning on using that cash for additional steam on their new drug which they're planning on rushing to IND sometime within the first 2 quarters of the year?
News 
Market Data 
Discover 
